MyHealthChecked PLC Directorate Change (5461U)
06 April 2021 - 11:30PM
UK Regulatory
TIDMMHC
RNS Number : 5461U
MyHealthChecked PLC
06 April 2021
MyHealthChecked plc
("MyHealthChecked" or "the Company")
Directorate Change
MyHealthChecked plc (AIM: MHC), the consumer home-testing
healthcare company, announces that Peter Dines, Non-executive
Director, has today stepped down from the Board. Peter is Chief
Operating Officer at Mercia Asset Management PLC(1) ("Mercia") and
is standing down to focus on other portfolio companies.
The Directorate change follows on from the successful roll-out
of a new corporate strategy for growth in 2021 and beyond, which
has seen MyHealthChecked focus on bringing further simple,
reliable, affordable health tests to market.
Peter Dines commented: "Having been associated with the Company
prior to the public listing and living through the evolution of the
senior management team in recent years, I am delighted that under
Penny's leadership the company is now well placed to execute its
new strategy and deliver further growth. The news today announcing
the agreement with Boots is a natural time to step down in order to
focus on other portfolio activities and I wish the company
continued success for the future."
Adam Reynolds, Non-executive Chairman of MyHealthChecked, said :
"We are incredibly grateful for the support provided by Peter and
we have benefitted enormously from his experience of
commercialising and scaling exciting medtech companies. We continue
to benefit from the support of Mercia, as our largest shareholder,
including their participation in our most recent fundraising which
will fuel the next exciting stage of our growth and evolution as we
seek to become the UK's leading business-to-consumer testing
business."
This announcement contains inside information for the purposes
of Article 7 of EU Regulation 596/2014. The Directors of the
Company take responsibility for this announcement.
For further information please contact:
MyHealthChecked plc www.myhealthcheckedp lc .com
P enny McCormick , Chief Executive via Walbrook PR
Officer
Maddy Kennedy, Chief Financial
Officer
SPARK Advisory Partners Limited Tel: +44 (0)20 3368 3550
(NOMAD)
Neil Baldwin
Oberon Investments (Broker) Tel: +44 (0)203 179 5344
Mike Seabrook mikeseabrook@oberoninvestments.com
Walbrook PR Ltd (Media & Tel: +44 (0)20 7933 8780 or myhealthchecked@walbrookpr.com
IR)
Paul McManus Mob: +44(0)7980 541 893
Alice Woodings Mob: +44(0)7407 804 654
About MyHealthChecked PLC ( www.myhealthcheckedplc.com )
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted
pioneering UK healthcare company with two diverse, customer-facing
at-home testing brands in its portfolio:
MyHealthChecked is the umbrella brand of a range of at-home DNA
and RNA tests, now in development following the recent acquisition
of The Genome Store. The tests will be made available online, and
would be viable for over the counter purchase.
The MyHealthChecked portfolio has been identified as part of a
change in mindset as customers become more familiar with the
concept of accessible healthcare in the growing at home testing kit
market with a focus on accessibility at the right price, led by
UK-based experts.
Mylo targets the personalized mobile health market, with a
primary focus on hormone testing and increasing a woman's chances
of naturally getting pregnant, by enabling her to quantitively
track her levels of luteinizing hormone (LH) prior to
ovulation.
(1) Mercia Asset Management PLC is the ultimate parent company
of Mercia (General Partner) Limited as general partner of Mercia
Investment Plan LP ("Mercia GP"), and of the fund managers of both
the Mercia EIS Funds ("Mercia EIS") and Enterprise Ventures
(General Partner FY Seedcorn) Limited as general partner of Finance
Yorkshire Seedcorn LP ("FYSC"). Together, Mercia GP, Mercia EIS and
FYSC own 205,764,327 shares, representing c28.4% of the current
issued share capital of the Company.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOAZZGGDFVNGMZM
(END) Dow Jones Newswires
April 06, 2021 09:30 ET (13:30 GMT)
Concepta (LSE:CPT)
Historical Stock Chart
From Apr 2024 to May 2024
Concepta (LSE:CPT)
Historical Stock Chart
From May 2023 to May 2024